Literature DB >> 6771074

Circulating immune complexes containing anti-VIII antibodies in multi-transfused patients with haemophilia A.

M D Kazatchkine, Y Sultan, E J Burton-Kee, J F Mowbray.   

Abstract

Evidence for the presence of circulating immune complexes was found in thirty-four out of fifty-five samples from forty-seven patients with haemophilia A. In eleven patients the complexes, precipitated from the blood with polyethylene glycol, were digested with pepsin. The F(ab')2 antibody was tested, and found to have neutralizing activity against coagulant Factor VIII in two patients. In one of these no free antibody had ever been found in the plasma, while in the other the antibody was concentrated tenfold in the complex. In two other samples free without complexed antibody was found. In comparison, IgG-containing complexes were found in nine out of nineteen patients with von Willebrand's disease and no complexes were found in the sera from twelve multi-transfused thalassaemics. PEG precipitation is a useful technique for the preparation of concentrated immune complexes for further study such as antigen identification.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6771074      PMCID: PMC1538049     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  18 in total

1.  Letter: A more uniform measurement of factor VIII inhibitors.

Authors: 
Journal:  Thromb Diath Haemorrh       Date:  1975-12-15

2.  Asymptomatic liver disease in haemophiliacs.

Authors:  P M Mannucci; A Capitanio; E Del Ninno; M Colombo; F Pareti; Z M Ruggeri
Journal:  J Clin Pathol       Date:  1975-08       Impact factor: 3.411

3.  Antibodies to factor VIII. I. Variations in stability of antigen-antibody complexes in hemophilia A.

Authors:  J P Allain; D Frommel
Journal:  Blood       Date:  1973-09       Impact factor: 22.113

4.  Serum autoantibodies in hepatitis associated antigen (HAA) positive patients. A possible index of cell-mediated immunity to the associated-infective agent.

Authors:  F J Dudley; M J O'Shea; S Sherlock
Journal:  Clin Exp Immunol       Date:  1973-03       Impact factor: 4.330

5.  The purification of specific antibody as F(ab')2 by the pepsin digestion of antigen-antibody precipitates, and its application to immunoglobulin and complement antigens.

Authors:  P J Lachmann
Journal:  Immunochemistry       Date:  1971-01

6.  Immune complexes in hepatitis.

Authors:  J D Almeida; A P Waterson
Journal:  Lancet       Date:  1969-11-08       Impact factor: 79.321

7.  Haemolytic diffusion plate assays for factors B and D of the alternative pathway of complement activation.

Authors:  A Martin; P J Lachmann; L Halbwachs; M J Hobart
Journal:  Immunochemistry       Date:  1976-04

8.  The interaction of rheumatoid factor with hepatitis B surface antigen-antibody complexes.

Authors:  J A Markenson; C A Daniels; A L Notkins; J H Hoofnagle; J Gerety; L F Barker
Journal:  Clin Exp Immunol       Date:  1975-02       Impact factor: 4.330

9.  Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. Quantitation by binding to radiolabeled C1q.

Authors:  U E Nydegger; P H Lambert; H Gerber; P A Miescher
Journal:  J Clin Invest       Date:  1974-08       Impact factor: 14.808

10.  Immunologic studies of antihemophilic factor (AHF, factor VIII). V. Immunologic properties of AHF subunits produced by salt dissociation.

Authors:  M E Rick; L W Hoyer
Journal:  Blood       Date:  1973-11       Impact factor: 22.113

View more
  5 in total

1.  Product-dependent anti-factor VIII antibodies.

Authors:  S Butenas; J Krudysz-Amblo; G E Rivard; K G Mann
Journal:  Haemophilia       Date:  2013-04-04       Impact factor: 4.287

Review 2.  Characteristics, mechanisms of action, and epitope mapping of anti-factor VIII antibodies.

Authors:  Géraldine Lavigne-Lissalde; Chantal Rothschild; Claire Pouplard; Priscilla Lapalud; Yves Gruel; Jean-François Schved; Claude Granier
Journal:  Clin Rev Allergy Immunol       Date:  2009-10       Impact factor: 8.667

3.  Quantitation of anti-factor VIII antibodies in human plasma.

Authors:  Jolanta Krudysz-Amblo; Behnaz Parhami-Seren; Saulius Butenas; Kathleen E Brummel-Ziedins; Edward D Gomperts; Georges E Rivard; Kenneth G Mann
Journal:  Blood       Date:  2009-01-14       Impact factor: 22.113

Review 4.  Management of factor VIII inhibitors.

Authors:  Donna M Dimichele
Journal:  Int J Hematol       Date:  2006-02       Impact factor: 2.490

5.  Circulating immune complexes as markers of response to chemotherapy in malignant teratomas and gestational trophoblastic tumours.

Authors:  R H Begent; K A Chester; L C Walker; D F Tucker
Journal:  Br J Cancer       Date:  1982-02       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.